(Date:1/7/2009)...PHILADELPHIA A study published in Cancer Prevent...on for Cancer Research, identifies components of b..., Researchers at the Ohio State Comprehensive Can...vonoids in black raspberries, inhibited growth and...ated with an esophageal carcinogen. , "Our data...
(Date:1/7/2009)...GAINESVILLE, Fla. Mercury pollution has already s...ss fish, but it could become a more pressing conce... appears in a recent issue of the journal Oecolog...otany at the University of Florida and the paper,s...er trees growing in air enriched with carbon dioxi...
(Date:1/7/2009)...A remarkable new discovery shows the four-eyed spo...e mirrors, rather than lenses, to focus light in i...niversity of Bristol, said: "In nearly 500 million... of vertebrate species living and dead, this is th...tical problem faced by all eyes how to make an im...
(Date:1/7/2009)..., COLUMBUS, Ohio Influenza,s ability to resist t...n Asia and Russia should serve as a cautionary tal... the event of widespread avian flu infection in hu...ost 700 genome sequences of avian influenza strain...esistance to a class of antiviral drugs called ada...
Breaking Biology News(10 mins):To climate-change worries, add 1 more: Extended mercury threat 2To climate-change worries, add 1 more: Extended mercury threat 3Spookfish uses mirrors for eyes 2Study: Excessive use of antiviral drugs could aid deadly flu 2Study: Excessive use of antiviral drugs could aid deadly flu 3Study: Excessive use of antiviral drugs could aid deadly flu 4Study: Excessive use of antiviral drugs could aid deadly flu 5Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD NP in Patients with Heart Failure 8250 1Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD NP in Patients with Heart Failure 8250 2Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD NP in Patients with Heart Failure 8250 3Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD NP in Patients with Heart Failure 8250 4Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD NP in Patients with Heart Failure 8250 5Insmed to Seek Shareholder Approval for Reverse Split 8248 1Insmed to Seek Shareholder Approval for Reverse Split 8248 2Insmed to Seek Shareholder Approval for Reverse Split 8248 3Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 1Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 2Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 3Frost 26 Sullivan Acknowledges Syntec Optics Unwavering Focus on Innovation and Strategies to Improve Profitability 27339 4MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman 26 Renshaw Healthcare Conference 27336 1MiddleBrook to Webcast Management Presentation at the 10th Annual Rodman 26 Renshaw Healthcare Conference 27336 2(Date:1/8/2009)... Amicus Therapeutics (Na... J. Barer, Ph.D., to its Board of Directors. Dr. ...tive Officer of Celgene Corporation. As an indust...gement experience and a reputation as a trusted an...e into one of the world,s preeminent biopharmaceut...
(Date:1/7/2009)...y 7, 2008 Researchers from Harvard University and...ured, for the first time, a repulsive quantum mech...for a wide range of new nanotechnology application...L. Wallace Professor of Applied Physics at Harvard...), will be published as the January 8 cover story ...
(Date:1/7/2009)...Jan. 7 Par Pharmaceutic...ng at the 27th Annual J.P. Morgan Healthcare Confe...the Westin St. Francis Hotel. , , The audio-o...P. Morgan website at http://metameetings.com/webc...ebsite at www.parpharm.com . A replay will be av...
(Date:1/7/2009)... Sangart, Inc., a privately held,b...development and,commercialization of oxygen-thera...uring that includes the addition of four key leade...rk force, primarily in the product manufacturing,...n rate and refocuses,Sangart,s business units on ...
Breaking Biology Technology:Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors 2Researchers measure elusive repulsive force from quantum fluctuations 2Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 2Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 3...f EagleSight software version 3.1 , Michel...Orr ,Stratagene Cloning Systems, Inc. , With t....1,researchers have the ability to automaticall...lates. Researchers can use the versatile features ...flexible background-division settings,adjustabl...
... ,,,, , Convenient, t...streamline transformation procedures , ... , , , Julie Bonnar...Banks , , Stratagene , ... The , new 96Pack Gold , com...
...,, , complete control system for inducible...eter Vaillancourt ,Stratagene , The complete c...ws tight,control of gene expression in a wide ra...ter used in the system is naturally repressed in t...(ponA). In a double-stable cell line, a linear,d...
... Characterize gene distribution in your cDNA ,..., We introduce six pairs of control RT-PCR primer...e transcripts with various expression levels. Thes...synthesis has been effective for,all abundance c...ear full-length,cDNA species are present for tho...
Other Biology Technology:Counting Colonies or Plaques Directly from Images of Agar Plates 2Counting Colonies or Plaques Directly from Images of Agar Plates 3Counting Colonies or Plaques Directly from Images of Agar Plates 4Counting Colonies or Plaques Directly from Images of Agar Plates 5Highest Possible Transformation Efficiencies for High-Throughput , Applications 2Highest Possible Transformation Efficiencies for High-Throughput , Applications 3Highest Possible Transformation Efficiencies for High-Throughput , Applications 4Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 2Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 3Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 4Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 5Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 6Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 7Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in,Mammalian Cells 8Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance 2Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance 3Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance 4Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance 5Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance 6Whole blood is collected from mice (Swiss Webster, 8-10 weeks old,either sex) and processed within 45 minutes of collection. The complement is then filtered and pooled on ice, bottled and stored at -
...ncorporating the sophisticated DirectDrive archite...e new Varian NMR System is undeniably the most adv...an NMR System features parallel controllers for ea...se sequence programming power with functionality a...
Anti-HMGN2/HMG-17 Immunogen : Recombinant human HMGN2/HMG-17 Formulation: 0.2M Tris-glycine, pH7.4, 5mg/ml BSA, 0.15M NaCl, 0.05% sodium azide before the addition of glycerol to 30% Quality Assuranc
Luminometers
Biology Products: